Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CareDx, Inc.CDNA · Entity 4344 | Director | July 07, 2025 | July 10, 2025 |
| Kyverna Therapeutics, Inc.KYTX · Entity 5452 | Director · Chief Executive Officer | February 07, 2024 | February 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CareDx, Inc.
Report date July 07, 2025 · Filed July 10, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 308,846 |
Reported balance
After 2025-07-07 transaction · row 1
1 source rowRow 1 · 2025-07-07 · Sale · Disposed 10,000 · Balance 308,846 F1: The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 21, 2024. F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.40 to $18.86 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 21, 2024.
F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.40 to $18.86 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Kyverna Therapeutics, Inc.
Report date February 07, 2024 · Filed February 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 58,220 |
Reported balance
Holding disclosure · report date 2024-02-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 58,220 |
| Common StockSEC Table I · non-derivative | IndirectBy The Maag Family Irrevocable Trust | 349,321 |
Reported balance
Holding disclosure · report date 2024-02-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 349,321 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.83 · Expires 2033-11-05 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2024-02-07 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F1: 25% of the original number of shares subject to the option shall vest on January 1, 2025, and 1/48th of the original number of shares subject to the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.33 · Expires 2033-07-12 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2024-02-07 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F2: 25% of the original number of shares subject to the option shall vest on July 1, 2024, and 1/48th of the original number of shares subject to the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.15 · Expires 2032-11-21 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2024-02-07 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance Not disclosed F3: 25% of the original number of shares subject to the option vested on October 13, 2023, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% of the original number of shares subject to the option shall vest on January 1, 2025, and 1/48th of the original number of shares subject to the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.
F2: 25% of the original number of shares subject to the option shall vest on July 1, 2024, and 1/48th of the original number of shares subject to the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.
F3: 25% of the original number of shares subject to the option vested on October 13, 2023, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Miromatrix Medical Inc.
Report date December 12, 2023 · Filed December 13, 2023
Section 16 reporting ended · disclosed 2023-12-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 58,368 |
Reported balance
After 2023-12-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-12-12 · Other · Disposed 62,092 · Balance 58,368 F1: Shares tendered and accepted pursuant to the terms of an offer conducted pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), by and among the Issuer, United Therapeutics Corporation ("Parent") and Morpheus Subsidiary Inc., dated as of October 29, 2023, for consideration consisting of (i) $3.25 per share, payable in cash, without interest and less any required withholding taxes (the "Cash Consideration"), plus (ii) one contractual, non-tradeable contingent value right per share (each, a "CVR"). F2: Each CVR entitles the reporting person to potentially receive contingent payments of up to an aggregate of $1.75 per CVR, without interest and less any required withholding taxes, upon the achievement of a specified milestone in accordance with the terms and subject to the conditions of a contingent value rights agreement (the "CVR Agreement"), dated as of December 12, 2023, by and between Parent and Continental Stock Transfer & Trust Company. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-12-13 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2023-12-13 · Disposition to issuer · Disposed 58,368 · Balance 0 F3: Previously unvested restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's common stock. F4: In connection with the closing under the Merger Agreement, each outstanding RSU award was cancelled and exchanged for the right to receive (i) a cash payment equal to (x) the total numbers of shares subject to the RSU award multiplied by (y) the Cash Consideration and (ii) one CVR with respect to each share subject to such RSU award. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares tendered and accepted pursuant to the terms of an offer conducted pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), by and among the Issuer, United Therapeutics Corporation ("Parent") and Morpheus Subsidiary Inc., dated as of October 29, 2023, for consideration consisting of (i) $3.25 per share, payable in cash, without interest and less any required withholding taxes (the "Cash Consideration"), plus (ii) one contractual, non-tradeable contingent value right per share (each, a "CVR").
F2: Each CVR entitles the reporting person to potentially receive contingent payments of up to an aggregate of $1.75 per CVR, without interest and less any required withholding taxes, upon the achievement of a specified milestone in accordance with the terms and subject to the conditions of a contingent value rights agreement (the "CVR Agreement"), dated as of December 12, 2023, by and between Parent and Continental Stock Transfer & Trust Company.
F3: Previously unvested restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's common stock.
F4: In connection with the closing under the Merger Agreement, each outstanding RSU award was cancelled and exchanged for the right to receive (i) a cash payment equal to (x) the total numbers of shares subject to the RSU award multiplied by (y) the Cash Consideration and (ii) one CVR with respect to each share subject to such RSU award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 07, 2021 Filed Sep 8, 2021 00:36 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 925 | $6.31 | $5,836.75 |
DisclosureSEC source: 0001217234-21-000210 · wf-form4_163106136222067.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:50 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 6,198 | $81.54 | $505,384.92 |
DisclosureSEC source: 0001217234-21-000200 · wf-form4_162863222691258.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,308 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. F2 · balance_after: Includes 250 shares acquired pursuant to the Issuer's 2014 Employee Stock Purchase Plan. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:56 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 94 | $24.35 Strike: $24.35 | $2,288.90 |
DisclosureSEC source: 0001217234-21-000196 · wf-form4_162854256463516.xml · derivative · entry 10 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,253 Underlying: Common Stock · 94 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:56 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 926 | $6.31 Strike: $6.31 | $5,843.06 |
DisclosureSEC source: 0001217234-21-000196 · wf-form4_162854256463516.xml · derivative · entry 9 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,792 Underlying: Common Stock · 926 shares Expires 2028-01-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:56 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,938 | $12.24 Strike: $12.24 | $48,201.12 |
DisclosureSEC source: 0001217234-21-000196 · wf-form4_162854256463516.xml · derivative · entry 8 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Stock · 3,938 shares Expires 2028-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · derivative.exercise_date: 1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:56 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 94 | $24.35 | $2,288.90 |
DisclosureSEC source: 0001217234-21-000196 · wf-form4_162854256463516.xml · nonDerivative · entry 5 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:56 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 926 | $6.31 | $5,843.06 |
DisclosureSEC source: 0001217234-21-000196 · wf-form4_162854256463516.xml · nonDerivative · entry 4 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,162 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:56 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 3,938 | $12.24 | $48,201.12 |
DisclosureSEC source: 0001217234-21-000196 · wf-form4_162854256463516.xml · nonDerivative · entry 3 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:56 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 6,904 | $83.27 | $574,919.55 |
DisclosureSEC source: 0001217234-21-000196 · wf-form4_162854256463516.xml · nonDerivative · entry 2 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,298 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.01 to $83.75, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:56 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 3,096 | $82.81 | $256,393.38 |
DisclosureSEC source: 0001217234-21-000196 · wf-form4_162854256463516.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,202 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.00 to $83.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 22:31 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,312 | $12.24 Strike: $12.24 | $28,298.88 |
DisclosureSEC source: 0001217234-21-000171 · wf-form4_162569702615853.xml · derivative · entry 8 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,188 Underlying: Common Stock · 2,312 shares Expires 2028-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · derivative.exercise_date: 1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 22:31 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 4,958 | $90.63 | $449,343.54 |
DisclosureSEC source: 0001217234-21-000171 · wf-form4_162569702615853.xml · nonDerivative · entry 5 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,298 F5 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 22:31 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 5,500 | $91.23 | $501,783.70 |
DisclosureSEC source: 0001217234-21-000171 · wf-form4_162569702615853.xml · nonDerivative · entry 4 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,256 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.04 to $91.33, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 22:31 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 2,400 | $90.55 | $217,309.44 |
DisclosureSEC source: 0001217234-21-000171 · wf-form4_162569702615853.xml · nonDerivative · entry 3 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,756 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.03 to $90.98, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 22:31 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 2,100 | $89.48 | $187,909.05 |
DisclosureSEC source: 0001217234-21-000171 · wf-form4_162569702615853.xml · nonDerivative · entry 2 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,156 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.00 to $89.96, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 22:31 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 2,312 | $12.24 | $28,298.88 |
DisclosureSEC source: 0001217234-21-000171 · wf-form4_162569702615853.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 374,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 30, 2021 Filed Feb 4, 2022 01:23 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 5,702 | $91.52 | $521,847.04 |
DisclosureSEC source: 0001217234-22-000027 · wf-form4_164393781432611.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,054 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| June 25, 2021 Filed Jun 25, 2021 23:54 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 395 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001217234-21-000156 · wf-form4_162466522097335.xml · derivative · entry 10 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,347 Underlying: Common Stock · 395 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 25, 2021 Filed Jun 25, 2021 23:54 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 395 | $95.00 | $37,525.00 |
DisclosureSEC source: 0001217234-21-000156 · wf-form4_162466522097335.xml · nonDerivative · entry 5 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,944 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 25, 2021 Filed Jun 25, 2021 23:54 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 395 | $24.35 | $9,618.25 |
DisclosureSEC source: 0001217234-21-000156 · wf-form4_162466522097335.xml · nonDerivative · entry 4 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,339 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 23:54 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,291 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001217234-21-000156 · wf-form4_162466522097335.xml · derivative · entry 9 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,742 Underlying: Common Stock · 9,291 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 23:54 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 314 | $0.00 Strike: $6.31 | $0.00 |
DisclosureSEC source: 0001217234-21-000156 · wf-form4_162466522097335.xml · derivative · entry 8 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,718 Underlying: Common Stock · 314 shares Expires 2028-01-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 23:54 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 9,605 | $95.30 | $915,397.80 |
DisclosureSEC source: 0001217234-21-000156 · wf-form4_162466522097335.xml · nonDerivative · entry 3 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,944 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $95.76, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 23:54 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 9,291 | $24.35 | $226,235.85 |
DisclosureSEC source: 0001217234-21-000156 · wf-form4_162466522097335.xml · nonDerivative · entry 2 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 381,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 23:54 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 314 | $6.31 | $1,981.34 |
DisclosureSEC source: 0001217234-21-000156 · wf-form4_162466522097335.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 23, 2021 Filed Jun 25, 2021 13:12 UTC | Miromatrix Medical Inc. MIRO · Entity 96164 | GrantCommon Stock | 16,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-007036 · edgar.xml · nonDerivative · entry 2 Maag Peter · CIK 0001613855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,221 F2 · shares: RSUs that vest as follows: one year cliff vesting for first third, the remainder vest ratably each quarter for the next two years. Read SEC document |
| June 23, 2021 Filed Jun 25, 2021 13:12 UTC | Miromatrix Medical Inc. MIRO · Entity 96164 | GrantCommon Stock | 5,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-007036 · edgar.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,555 F1 · shares: Restricted Stock Units ("RSUs") that will fully vest on the earlier of the next annual meeting or one year from the date of the grant. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 21:52 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,522 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001217234-21-000138 · wf-form4_162344833726701.xml · derivative · entry 5 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,033 Underlying: Common Stock · 2,522 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 21:52 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 2,522 | $90.00 | $226,981.51 |
DisclosureSEC source: 0001217234-21-000138 · wf-form4_162344833726701.xml · nonDerivative · entry 2 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,944 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.015, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 21:52 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 2,522 | $24.35 | $61,410.70 |
DisclosureSEC source: 0001217234-21-000138 · wf-form4_162344833726701.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 374,466 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 00:27 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 978 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001217234-21-000124 · wf-form4_162328485574325.xml · derivative · entry 5 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,555 Underlying: Common Stock · 978 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 00:27 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 978 | $90.05 | $88,073.69 |
DisclosureSEC source: 0001217234-21-000124 · wf-form4_162328485574325.xml · nonDerivative · entry 2 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,944 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.22, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 00:27 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 978 | $24.35 | $23,814.30 |
DisclosureSEC source: 0001217234-21-000124 · wf-form4_162328485574325.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 22:41 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,467 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001217234-21-000122 · wf-form4_162319208921217.xml · derivative · entry 8 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,533 Underlying: Common Stock · 4,467 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 22:41 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,125 | $0.00 Strike: $12.24 | $0.00 |
DisclosureSEC source: 0001217234-21-000122 · wf-form4_162319208921217.xml · derivative · entry 7 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 3,125 shares Expires 2028-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · derivative.exercise_date: 1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 22:41 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 6,500 | $90.01 | $585,070.20 |
DisclosureSEC source: 0001217234-21-000122 · wf-form4_162319208921217.xml · nonDerivative · entry 4 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,944 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.06, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 22:41 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 20,000 | $85.03 | $1,700,682.00 |
DisclosureSEC source: 0001217234-21-000122 · wf-form4_162319208921217.xml · nonDerivative · entry 3 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378,444 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.60 to $85.31, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 22:41 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 4,467 | $24.35 | $108,771.45 |
DisclosureSEC source: 0001217234-21-000122 · wf-form4_162319208921217.xml · nonDerivative · entry 2 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 22:41 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 3,125 | $12.24 | $38,250.00 |
DisclosureSEC source: 0001217234-21-000122 · wf-form4_162319208921217.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 393,977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 01, 2021 Filed Jun 4, 2021 20:08 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 18,592 | $82.09 | $1,526,217.28 |
DisclosureSEC source: 0001217234-21-000115 · wf-form4_162283725775840.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,852 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| May 25, 2021 Filed May 27, 2021 21:04 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $27.17 Strike: $27.17 | $271,700.00 |
DisclosureSEC source: 0001217234-21-000109 · wf-form4_162214938522404.xml · derivative · entry 6 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,899 Underlying: Common Stock · 10,000 shares Expires 2029-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020. F5 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 25, 2020 and 1/48th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| May 25, 2021 Filed May 27, 2021 21:04 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 400 | $81.08 | $32,430.52 |
DisclosureSEC source: 0001217234-21-000109 · wf-form4_162214938522404.xml · nonDerivative · entry 3 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 409,444 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.04 to $81.19, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| May 25, 2021 Filed May 27, 2021 21:04 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 9,600 | $80.57 | $773,440.32 |
DisclosureSEC source: 0001217234-21-000109 · wf-form4_162214938522404.xml · nonDerivative · entry 2 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 409,844 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $80.95, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| May 25, 2021 Filed May 27, 2021 21:04 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 10,000 | $27.17 | $271,700.00 |
DisclosureSEC source: 0001217234-21-000109 · wf-form4_162214938522404.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020. Read SEC document |
| May 11, 2021 Filed May 12, 2021 22:53 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 87,128 | $12.24 Strike: $12.24 | $1,066,446.72 |
DisclosureSEC source: 0001217234-21-000099 · wf-form4_162085998376348.xml · derivative · entry 17 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,625 Underlying: Common Stock · 87,128 shares Expires 2028-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: 1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| May 11, 2021 Filed May 12, 2021 22:53 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 6,365 | $68.30 | $434,716.77 |
DisclosureSEC source: 0001217234-21-000099 · wf-form4_162085998376348.xml · nonDerivative · entry 11 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 409,444 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.015 to $68.60, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| May 11, 2021 Filed May 12, 2021 22:53 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 21,985 | $67.49 | $1,483,827.01 |
DisclosureSEC source: 0001217234-21-000099 · wf-form4_162085998376348.xml · nonDerivative · entry 10 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,809 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.01 to $68.01, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| May 11, 2021 Filed May 12, 2021 22:53 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 28,986 | $66.35 | $1,923,122.55 |
DisclosureSEC source: 0001217234-21-000099 · wf-form4_162085998376348.xml · nonDerivative · entry 9 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437,794 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.005 to $67.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| May 11, 2021 Filed May 12, 2021 22:53 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 29,792 | $65.83 | $1,961,132.88 |
DisclosureSEC source: 0001217234-21-000099 · wf-form4_162085998376348.xml · nonDerivative · entry 8 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 466,780 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $66.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| May 11, 2021 Filed May 12, 2021 22:53 UTC | CareDx, Inc. CDNA · Entity 4344 | Exercise / conversionCommon Stock | 87,128 | $12.24 | $1,066,446.72 |
DisclosureSEC source: 0001217234-21-000099 · wf-form4_162085998376348.xml · nonDerivative · entry 7 Maag Peter · CIK 0001613855 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,572 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.